Basel Medical Group Ltd (NASDAQ:BMGL) Short Interest Update

Basel Medical Group Ltd (NASDAQ:BMGL) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totaling 314,368 shares, an increase of 1,768.6% from the May 31st total of 16,824 shares. Approximately 20.2% of the company’s shares are sold short. Based on an average daily volume of 2,921,328 shares, the short-interest ratio is presently 0.1 days.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Marex Group plc bought a new stake in Basel Medical Group in the 2nd quarter valued at $25,000. Virtu Financial LLC boosted its stake in Basel Medical Group by 108.8% in the 3rd quarter. Virtu Financial LLC now owns 33,786 shares of the company’s stock worth $61,000 after purchasing an additional 17,608 shares during the period. Finally, Citadel Advisors LLC bought a new position in Basel Medical Group during the 3rd quarter worth about $169,000.

Basel Medical Group Trading Down 4.6%

Shares of NASDAQ BMGL traded down $0.32 during mid-day trading on Thursday, reaching $6.71. 6,483 shares of the company’s stock were exchanged, compared to its average volume of 150,642. Basel Medical Group has a twelve month low of $4.60 and a twelve month high of $54.60. The business has a fifty day simple moving average of $7.45 and a 200 day simple moving average of $7.77.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded shares of Basel Medical Group from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, June 15th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, the company currently has a consensus rating of “Sell”.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.